# XELOX With Capecitabine Maintenance or XELOX in Elderly Metastatic Adenocarcinoma of Stomach

> **NCT01798251** · PHASE2 · UNKNOWN · sponsor: **Harbin Medical University** · enrollment: 40 (estimated)

## Conditions studied

- Gastric Cancer

## Interventions

- **DRUG:** Oxaliplatin
- **DRUG:** Capecitabine

## Key facts

- **NCT ID:** NCT01798251
- **Lead sponsor:** Harbin Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-12
- **Primary completion:** 2014-12
- **Final completion:** 2015-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2013-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01798251

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01798251, "XELOX With Capecitabine Maintenance or XELOX in Elderly Metastatic Adenocarcinoma of Stomach". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01798251. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*